Arkin raises $100m for early-stage biotech fund

The main investors in Arkin Bio Ventures III together with Arkin Capital are Israeli institutional investors including Phoenix Finance, Clal Insurance, and Amitim pension fund

  News   Jan 14, 2026   0   96  Add to Reading List
Arkin raises $100m for early-stage biotech fund












Heart hologram and doctor, heart disease. Health care of the future. Modern Medical Science, Hi Tech Diagnostic Panel. Mixed medium, copy space (photo credit: SHUTTERSTOCK)
The main investors in Arkin Bio Ventures III together with Arkin Capital are Israeli institutional investors including Phoenix Finance, Clal Insurance, and Amitim pension fund
Read Original   

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow